Atlas Trials

Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

Clinical trial NCT03174587 · COMPLETED

Trial details

NCT number
NCT03174587
Sponsor
Corestemchemon, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lupus Nephritis
Start date
2017-05-30
Primary completion
2019-03-12
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.